Sign in
Taking peopleNo phase

FlowOx device treatment for people with diabetic foot ulcers

Tests the FlowOx device on toe blood pressure and wound size in diabetic foot ulcers.

Key facts

Who runs it
Lo Zhiwen Joseph
Where
Singapore1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study
Status
Recruiting
People taking part
30 people, planned
Started
3 Nov 2025
Planned end
2 Nov 2026
Type of study
Interventional
Treatments tested
  • FlowOx
Record updated
10 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with diabetes who have an open, long-lasting wound on the foot. They will use the FlowOx device at home for 1 hour twice a day for 12 weeks.

Age
21 to 99 years
Sex
All sexes
Disease stage
Open chronic wound on the foot. Toe systolic pressure below 90 mmHg on the leg to be treated, after any procedure to restore blood flow. The leg must be one that doctors aim to save.
Earlier treatment
No other experimental treatment in the 12 weeks before joining.
Biomarker or test result
Toe systolic pressure <90 mmHg on the leg to be treated.

Main reasons for not taking part

  • Known allergy to parts of the INP device
  • Another experimental treatment in the last 12 weeks
  • Pregnant women
  • People with problems in thinking or memory
  • Not able to use the device or follow the study plan

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 21-99
  • Diagnosed with diabetes mellitus
  • Toe systolic pressure <90 mmHg on the leg to be treated (after revascularization)
  • Open chronic wound on the foot
  • Ability to operate the treatment device, and willing to adhere to the study intervention regimen
  • Suitable for diabetic limb salvage

Who cannot take part

  • Treatment with another investigational intervention within the last 12 weeks prior to inclusion
  • Known allergic reactions to components of the INP device
  • Pregnant women or cognitively impaired participants

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 21 and 99 years old?

This trial is currently available in Singapore.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this trial is to investigate the safety and efficacy of 12 weeks treatment with FlowOx, for 1 hour twice daily, when used on patients with diabetic foot ulcers. The main question it aims to answer is whether treatment with FlowOx one hour in the morning and one hour in the evening for 12 weeks can improve toe arterial pressure and wound surface area compared to baseline.

Read full original descriptionShow less

Participants will have baseline assessments (i.e. toe pressure measurement and wound area measurement) performed on them and training on the use of FlowOx device will be provided to them in Visit 1. Participants will be tasked to use the FlowOx device (device will be loaned to them) for 1 hour twice daily. A phone call will be conducted 1 week after Visit 1 to follow up on the medical and user-related issues. At Week 6 (Visit 2), participants will be asked to come back for toe pressure and wound area measurement. At Week 12 (Visit 3), end of treatment assessments (i.e toe pressure and wound area measurement) will be performed. Compliance data will be acquired from the FlowOx device.

Their participation in the study will last for 12 weeks. Participants will be asked to use the FlowOx device for one hour, two times a day throughout the study period. They will need to visit the clinic 3 times in the course of the study.

The group in the trial

  • Treatment with FlowOxTreatment being tested

    Treatment: FlowOx

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study
Plain-language title
FlowOx device treatment for people with diabetic foot ulcersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07291817, who can take part
Record updated
10 July 2026